Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Bronchial Asthma With Borage and Echium Seed Oils

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of bronchial asthma~* Male or female 18 years to 65 years of age~* FEV1 50 to 90% of predicted, or personal best.~* Improvement of \>=12% FEV1 with bronchodilator~Exclusion Criteria:~* Pregnant or nursing~* Smoking history of \> 10 pack years or active smoking within the past year.~* Due to possible effects on leukotriene biosynthesis, use of the following asthma treatments within the preceding month will be exclusion criteria:~  * leukotriene modifying drugs,~ * theophylline~ * oral steroids.~ * dietary supplements with fatty acids or other products that may interfere with leukotriene generation.~* Treatment within the previous three months with omalizumab (monoclonal antibody directed against IgE)~* Subjects will not be permitted to take non-steroidal anti-inflammatory drugs in the week prior to any measurements of ex vivo leukotriene generation because of their effects on leukotriene biosynthesis via inhibition of prostaglandin generation.~* A history of aspirin-sensitive asthma~* Significant abnormalities in CBC, differential white cell count, renal function, and liver function, or urinalysis.~* Any serious co-morbid medical condition.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1: Borage Seed Oil and Echium Seed Oil (Type: EXPERIMENTAL): Borage/Echium plant seed oils: 2 g/day of borage seed oil and 7 g/day of echium seed oil to provide 1.6 g/day of GLA and 0.9 g/day of SDA.
- 2: Placebo Comparator (Type: PLACEBO_COMPARATOR): Placebo comparator: 9 g/day corn oil

Based on this trial design, predict the completion outcome and termination type (if applicable).